genentech vacaville closing:Genentech to close South SF production facility
Genentech to close South SF production facility
2023年3月27日—BiotechdrugmanufacturerGenentechannounceditisclosingitsSouthSanFranciscoproductionfacility.。其他文章還包含有:「GenentechclosingSouthSFfacility」、「GenentechissellingmajorproductionplantintheBayArea」、「GenentechmanufacturingplantinVacavillepiquing...」、「GenentechtocloseplantnearSacramentoafterBayArealayoffs」、「Genentech'sClosureofSacramentoPlantandLayoffs」、「Persona...
查看更多 離開網站Genentech closing South SF facility
https://www.sfgate.com
The biotech drug manufacturer Genentech will close its South San Francisco production facility and lay off roughly 265 employees who work ...
Genentech is selling major production plant in the Bay Area
https://www.sfchronicle.com
Roche Holding AG, the parent company of Genentech, announced May 31 that it will sell its drug manufacturing plant in Vacaville, one of its ...
Genentech manufacturing plant in Vacaville piquing ...
https://www.bizjournals.com
As Genentech plans to divest manufacturing plant, Vacaville officials already fielding interest ... They made clear to us, they're not closing ...
Genentech to close plant near Sacramento after Bay Area layoffs
https://www.sfgate.com
Genentech's Closure of Sacramento Plant and Layoffs
https://www.linkedin.com
Genentech is expanding their biologics manufacturing network and will add hundreds of jobs at their Vacaville facility as part of this expansion ...
Personalized pipeline driving Roche to exit Vacaville site
https://bioprocessintl.com
At this time, there is no impact to operations or to our employees.” According to Reuters, the plant will close between 2028 and 2029. The news ...
Roche looking to sell or shut down California biologic drug ...
https://www.reuters.com
S) plans to sell its 800-employee drug manufacturing plant in Vacaville, California, or it will shut the factory by 2029, according to e-mailed ...
Roche to sell California plant or shutter it by 2029
https://www.fiercepharma.com
Roche snapped up the Vacaville site as part of its 2009 buyout of Genentech. It was closed for several years before the Swiss drugmaker ...